Trials / Completed
CompletedNCT04387968
Epidemiological Study of the Covid-19 Presto Test - The "COVIDOR" Study
Epidemiological Study of the Covid-19 Presto Test Among Agents of the Local Authorities of CCTVL, Region Centre Val de Loire and Orleans Métropole. Correlation of IgM Level According to Contact With the Public
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,228 (actual)
- Sponsor
- Raphael Serreau · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The "COVIDOR" epidemiological study. Our study would be the first at the community level in Orleans Métropole, aiming to determine the link between a positive IgM level on the serological test and a healthy carrier of covid-19 in agents in contact with the public. It would provide epidemiological surveillance of anti-covid-19 immunity in the community
Detailed description
The metropolitan area of Orléans Métropole has 6,700 agents divided into 250 different trades and consequently multiple exposures and risks. The global covid-19 pandemic has affected France and the Loiret, the sarscov-2 coronavirus, has infected several thousand people. On May 7, 2020, there were 75 deaths at the CHRO hospital in Orleans, excluding EHPAD. The contamination rate of the population of the Loiret department has been estimated at 5.6% of the population by Public Health France. This rate is very low and does not allow the use of serological screening tests because of too many false positives or false negatives, there should be a prevalence of the disease greater than 60%. The French health authorities do not recommend the use of a screening test at the present time in view of the uncertainties of the results of this test. The Loiret Management Center, the Department and Orléans Métropole have decided to offer a covid-19 serological screening test, the covid-19 presto test, to voluntary territorial agents regardless of their return to work following the national "deconfinement "on May 11, 2020 This can only be done through an epidemiological surveillance study validated as part of a research protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Covid-19 presto test | Use an auto-test in 15 minutes get the results about covid-19 anticorps |
Timeline
- Start date
- 2020-08-24
- Primary completion
- 2021-07-13
- Completion
- 2021-10-04
- First posted
- 2020-05-14
- Last updated
- 2021-10-05
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04387968. Inclusion in this directory is not an endorsement.